Feed:Trial Acronyms
Jump to navigation
Jump to search
{
"trial_acronyms" : {
"A-HeFT" : "African-American Heart Failure Trial",
"SPARCL" : "Stroke Prevention by Aggressive Reduction in Cholesterol Levels",
"RE-COVER" : "Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism",
"RALES" : "Randomized Aldactone Evaluation Study",
"ASPIRE" : "Aspirin to Prevent Recurrent Venous Thromboembolism",
"TACTICS-TIMI 18" : "Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban",
"EASE" : "Early Surgery versus Conventional Treatment in Infective Endocarditis",
"ISAR-REACT 5" : "Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 5 Trial",
"TRISS" : "Transfusion Requirements in Septic Shock",
"TRAPS" : "Trial on Rivaroxaban in AntiPhospholipid Syndrome",
"HEMO" : "Hemodialysis",
"BEST" : "The Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation",
"ALBIOS" : "Albumin Italian Outcome Sepsis",
"JUPITER" : "Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin",
"ESCAPE" : "Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness",
"PIONEER-HF" : "comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode",
"ICAP" : "Evaluation of additive benefit of colchicine to conventional therapy in acute pericarditis",
"ANNEXA" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of FXA Inhibitors",
"EMPEROR-Preserved" : "Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction",
"STAMPEDE" : "Surgical Treatment and Medications Potentially Eradicate Diabetes Efficiently",
"EUROPA" : "European Trial on Reduction of Cardiac Events with Perindopril in Patients with Stable Coronary Artery Disease",
"DPP" : "Diabetes Prevention Program",
"WISDOM" : "Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management",
"PCPT" : "Prostate Cancer Prevention Trial",
"SUSTAIN-6" : "Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes",
"HEAT" : "Permissive Hyperthermia through Avoidance of Acetaminophen in Known or Suspected Infection in the Intensive Care Unit",
"COPERNICUS" : "Carvedilol Prospective Randomized Cumulative Survival",
"SCD-HeFT" : "Sudden Cardiac Death in Heart Failure Trial",
"DanGer Shock" : "Danish–German Cardiogenic Shock",
"Look AHEAD" : "Look Action for HEAlth in Diabetes",
"HEARTMATE II" : "Advanced heart failure treated with continuous-flow left ventricular assist device",
"STOP-NIDDM" : "Study to Prevent NIDDM",
"CABANA" : "Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation",
"RE-LY" : "Randomized Evaluation of Long-Term Anticoagulation Therapy",
"TREAT" : "Trial to Reduce Cardiovascular Events With Aranesp Therapy",
"SPYRAL HTN-ON MED" : "Global Clinical Study of Renal Denervation With the Symplicity Spyral Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy",
"EPIC-CAD" : "Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease",
"HORIZON-PFT" : "Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly - Pivotal Fracture Trial",
"CORAL" : "Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis",
"SYNTAX" : "Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery",
"PIOPED II" : "Prospective Investigation of Pulmonary Embolism Diagnosis II",
"EUCLID" : "Examining use of ticagrelor in peripheral artery disease",
"COAPT" : "Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation",
"Oscillate" : "Oscillation for Acute Respiratory Distress Syndrome Treated Early",
"ATLAS" : "Adjuvant Tamoxifen: Longer Against Shorter",
"IDEAL-ICU" : "Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit",
"ACT I" : "Stent versus endarterectomy for asymptomatic carotid stenosis",
"DIVA" : "Rationale and design of the drug-eluting stents vs bare-metal stents in saphenous vein graft angioplasty",
"TIMACS" : "The Timing of Intervention in Acute Coronary Syndromes",
"NINDS" : "National Institute of Neurological Disorders and Stroke rt-PA Stroke Study",
"PARADIGM-HF" : "Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure",
"TRITON-TIMI 38" : "Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis in Myocardial Infarction 38",
"HYVET" : "Hypertension in the Very Elderly Trial",
"CREDENCE" : "Canagliflozin and Renal Events in Diabetes and Nephropathy Clinical Evaluation",
"PRORATA" : "Procalcitonin to Reduce Antibiotic Treatments in Acutely ill patients",
"PROFESS" : "Prevention Regimen for Effectively Avoiding Second Strokes",
"CANTOS" : "Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)",
"TALC" : "Tiotropium Bromide as an Alternative to Increased Inhaled Glucocorticoid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid",
"AASK" : "African American Study of Kidney Disease and Hypertension",
"NORSTENT" : "Drug-Eluting or Bare-Metal Stents for Percutaneous Coronary Intervention in Stable or Unstable Coronary Artery Disease",
"CHOIR" : "Correction of Hemoglobin and Outcomes in Renal Insufficiency",
"BASALT" : "Best Adjustment Strategy for Asthma in the Long Term",
"SMART" : "Isotonic Solutions and Major Adverse Renal Events Trial",
"AMAZES" : "Azithromycin on Asthma Exacerbations and Quality of Life in Adults With Persistent Uncontrolled Asthma",
"POISE-2 ASA" : "Perioperative ischemic evaluation 2 aspirin arm",
"POINT" : "Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial",
"CvLPRIT" : "Complete Versus Lesion-Only Primary PCI Trial",
"CATIE" : "Clinical Antipsychotic Trials of Intervention Effectiveness",
"ACCORD BP" : "ACCORD Study Group",
"ISCHEMIA" : "International Study of Comparative Health Effectiveness with Medical and Invasive Approaches",
"FAME 2" : "FFR vs. Angiographyfor Multivessel Evaluation 2",
"ARDSNet" : "Acute Respiratory Distress Syndrome Network",
"SPICE III" : "Sedation Practice in Intensive Care Evaluation",
"OVIVA" : "Oral versus Intravenous Antibiotics for Bone and Joint Infection",
"DAWN" : "DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention with Trevo",
"TOPPS" : "Trial of Prophylactic Platelets",
"ProCESS" : "Protocolized Care for Early Septic Shock",
"ADVANCE" : "Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation",
"ARISE" : "Australasian Resuscitation in Sepsis Evaluation",
"CREST" : "Carotid Revascularization Endarterectomy vs. Stenting Trial",
"SPACE" : "Strategies for Prescribing Analgesics Comparative Effectiveness",
"DOSE" : "Diuretic Optimization Strategies Evaluation",
"PROSEVA" : "Proning Severe ARDS Patients",
"WASID" : "Warfarin-Aspirin Symptomatic Intracranial Disease",
"SAFE" : "Saline versus Albumin Fluid Evaluation",
"MADIT-CRT" : "Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy",
"POET" : "Partial Oral Treatment of Endocarditis",
"SPS3-BP" : "Secondary Prevention of Small Subcortical Strokes-Blood Pressure",
"PREVAIL" : "Prospective Randomized Evaluation of the Watchman LAA Closure Device In Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy",
"FRISC-II" : "FRagmin and Fast Revascularisation during InStability in Coronary artery disease-II",
"CHANCE" : "Clopidogrel in High-risk patients with Acute Nondisabling Cerebrovascular Events",
"CORTICUS" : "Corticosteroid Therapy of Septic Shock",
"UKPDS" : "United Kingdom Prospective Diabetes Study",
"AIRTRIP" : "AnakInRa for Treatment of Recurrent Idiopathic Pericarditis",
"AFFIRM" : "Atrial Fibrillation Follow-up Investigation of Rhythm Management",
"EINSTEIN CHOICE" : "Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism",
"COURAGE" : "Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation",
"AVOID" : "Comparing Oxygen with normal air in patients with ST-Segment Elevation Myocardial Infarction who are not hypoxic.",
"SAVE" : "Survival and Ventricular Enlargement Trial",
"PIONEER AF-PCI" : "Open-Label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects with AF who Undergo Percutaneous Coronary Intervention",
"BLOCK-HF" : "Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block",
"NASCET" : "North American Symptomatic Carotid Endarterectomy Trial",
"CAPRICORN" : "Carvedilol Post-Infarct Survival Control in LV Dysfunction",
"ESSENCE" : "Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group",
"CRASH-2" : "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2",
"APROCCHSS" : "Recombinant Human Activated Protein C and Low Dose of Hydrocortisone and Fludrocortisone in Adult Septic Shock",
"3C" : "Cough Complication Cohort",
"AMBITION" : "Ambrisentan and Tadalafil in Patients with Pulmonary Arterial Hypertension",
"CHOICE" : "CHOICE is not an abbreviation per a communication with the research team",
"SELECT-D" : "Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism",
"AMPLIFY" : "Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy",
"STEP" : "Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients",
"PERC" : "Pulmonary Embolism Rule-Out Criteria",
"PRECISION" : "Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen",
"AIDA" : "Amsterdam Investigator-Initiated Absorb Strategy All-Comers Trial",
"PARTNER 3" : "Placement of Aortic Transcatheter Valves 3",
"V-HeFT" : "Vasodilator Heart Failure Trial",
"EPCAT II" : "Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty II",
"TTM" : "Target Temperature Management 33°C vs. 36°C after Out-of Hospital Cardiac Arrest",
"COGENT" : "Clopidogrel and the Optimization of Gastrointestinal Events Trial",
"COMMIT/CCS-2" : "ClOpidogrel and Metoprolol in Myocardial Infarction Trial / Second Chinese Cardiac Study",
"GUSTO" : "Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries",
"SOCRATES" : "Ticagrelor versus aspirin in stroke/TIA",
"PROWESS-SHOCK" : "Prospective Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis and Septic Shock",
"HOPE" : "Hemoglobin Oxygen Affinity Modulation to Inhibit HbS Polymerization",
"AVERROES" : "Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment",
"HACA" : "Hypothermia After Cardiac Arrest",
"CHARISMA" : "Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance",
"DAPA-HF" : "Dapagliflozin in Heart Failure",
"RAVE" : "Rituximab in ANCA-Associated Vasculitis",
"ARREST" : "Adjunctive rifampicin for Staphylococcus Aureus Bacteraemia",
"NAVIGATE ESUS" : "New Approach riVaroxaban Inhibition of Factor Xa in a Global trial versus ASA to prevenT Embolism in Embolic Stroke of Undetermined Source\nof Undetermined Source",
"IDNT" : "Irbesartan Diabetic Nephropathy Trial",
"SOAP II" : "Sepsis Occurrence in Acutely Ill Patients II",
"REALITY" : "Restrictive and Liberal Transfusion Strategies in Patients With Acute Myocardial Infarction trial",
"TTM2" : "Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest 2",
"MERIT-HF" : "Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure",
"NSABP B-32" : "National Surgical Adjuvant Breast and Bowel Project Trial B-32",
"CLOSURE I" : "Evaluation of the STARFlex Septal Closure System in Patients with a Stroke and/or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale",
"RAFT" : "Resynchronization–Defibrillation for Ambulatory Heart Failure",
"SPAF" : "Stroke Prevention in Atrial Fibrillation",
"TRIUMPH" : "Transfusion Reduction Efficacy and Safety Clinical Investigation, a Randomized, Multicenter, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria",
"Novel START" : "Novel Symbicort Turbuhaler Asthma Reliever Therapy",
"VADT" : "Veterans Affairs Diabetes Trial",
"PREPIC 2" : "Prevention du Risque d'Embolie Pulmonaire par Interruption Cave 2",
"MOMENTUM 3" : "Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3",
"ERSPC" : "European Randomized Study of Screening for Prostate Cancer",
"PREPIC" : "Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group",
"TRICC" : "Transfusion Requirements in Critical Care",
"LoDoCo2" : "Low Dose Colchicine 2",
"REDUCE-IT" : "Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial",
"REDUCE" : "Reduction in the Use of Corticosteroids in Exacerbated COPD",
"HERA" : "Herceptin Adjuvant Trial",
"BARI 2D" : "Bypass Angioplasty Revascularization Investigation 2 Diabetes",
"TICORA" : "Tight Control of Rheumatoid Arthritis",
"DANISH" : "Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality",
"DANAMI-3 PRIMULTI" : "Third Danish Study of Optimal Acute Treatment of Patients with STEMI: Primary PCI in Multivessel Disease",
"PANTER" : "Minimally Invasive Step Up Approach versus Maximal Necrosectomy in Patients with Acute Necrotising Pancreatitis",
"RED-HF" : "Reduction of Events by Darbepoetin Alfa in Heart Failure",
"ATTR-ACT" : "The Transthyretin Amyloidosis Cardiomyopathy Clinical Trial",
"B-CONVINCED" : "Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode",
"EDIC" : "Epidemiology of Diabetes Interventions and Complications",
"RENAAL" : "Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan",
"FAIR-HF" : "IV Iron for Symptoms in Patients with HFrEF and Iron Deficiency",
"Blood-Pressure Reduction in Black Barbershops" : "Blood-Pressure Reduction in Black Barbershops",
"StiL" : "Study Group Indolent Lymphomas",
"RESCUEicp" : "Randomised Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intracranial Pressure",
"EcLiPSE" : "Emergency treatment with Levetiracetam or Phenytoin in convulsive Status Epilepticus in children",
"ALLHAT" : "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial",
"CLOT" : "Comparison of Low Molecular Weight Heparin Versus Oral Anticoagulant Therapy for Long Term Anticoagulation in Cancer Patients With Venous Thromboembolism",
"TRICS III" : "Transfusion Requirements in Cardiac Surgery",
"MITIGATE" : "A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection for Adults and Children in Emergency Department and Urgent Care Settings",
"ISIS-2" : "Second International Study of Infarct Survival",
"BeSt" : "Behandel-Strategeieën (\"treatment strategies\" in Dutch)",
"PROVE IT-TIMI 22" : "Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22",
"EVEREST" : "Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan",
"CULPRIT-SHOCK" : "Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock",
"NETT" : "National Emphysema Treatment Trial",
"APEX" : "Acutely Medically Ill VTE Prevention with Extended Duration Betrixaban",
"MARINER" : "Medically Ill Patient Assessment of Rivaroxaban versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk",
"AID-ICU" : "Agents Intervening against Delirium in the Intensive Care Unit",
"MIST2" : "Second MIST trial",
"TOPCAT" : "Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist",
"DAPT" : "Dual Antiplatelet Therapy",
"SPS3-Clopidogrel+ASA" : "Secondary Prevention of Small Subcortical Strokes clopidogrel+ASA",
"CARRESS-HF" : "Cardiorenal Rescue Study in Acute Decompensated Heart Failure",
"DASH" : "Dietary Approaches to Stop Hypertension",
"WARSS" : "Warfarin–Aspirin Recurrent Stroke Study",
"MUSTT" : "Multicenter Unsustained Tachycardia Trial",
"WOSCOPS" : "West of Scotland Coronary Prevention Study",
"OASIS-5" : "Fifth Organization to Assess Strategies in Acute Ischemic Syndromes",
"V-HeFT II" : "Vasodilator Heart Failure Trial II",
"FACTT" : "Fluids and Catheters Treatment Trial",
"CIRT" : "Cardiovascular Inflammation Reduction Trial",
"SOLVD" : "Studies of Left Ventricular Dysfunction",
"MSH" : "Multicenter Study of Hydroxyurea in Sickle-Cell Anemia",
"iPrEx" : "Iniciativa Profilaxis Pre Exposicion (\"Preexposure Prophylaxis Initiative\")",
"ORBIT-AF" : "Outcomes Registry for Better Informed Treatment of Atrial Fibrillation",
"EXTRA" : "A Study of Omalizumab/Xolair in Subjects With Moderate to Severe Persistent Asthma",
"EMBRACE" : "30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation after a Cerebral Ischemic Event",
"SPRINT" : "Systolic Blood Pressure Intervention Trial",
"iFR-SWEDEHEART" : "Instantaneous Wave-free Ratio versus Fractional Flow Reserve in Patients with Stable Angina Pectoris or Acute Coronary Syndrome",
"RESPECT" : "Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment",
"CAST I" : "Cardiac Arrhythmia Suppression Trial",
"LESS" : "Lumbar Epidural Steroid Injections for Spinal Stenosis",
"RECOVERY" : "Randomized Evaluation of Covid-19 Therapy",
"FEAST" : "Fluid Expansion as Supportive Therapy",
"TNT" : "Treating to New Targets",
"ACTT-1" : "Adaptive Covid-19 Treatment Trial",
"DAVID" : "Dual-chamber pacing or ventricular backup pacing in ICD patients",
"CAPRIE" : "Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events",
"IRONOUT-HF" : "Iron Repletion Effects on Oxygen Uptake in Heart Failure",
"ACOSOG Z0011" : "The American College of Surgeons Oncology Group (ACOSOG) Z0011",
"MADIT-II" : "Multicenter Automatic Defibrillator Implantation Trial II",
"AATAC" : "Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device",
"TIPPS" : "Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia",
"DCCT" : "Diabetes Control and Complications Trial",
"4S" : "Scandinavian Simvastatin Survival Study",
"ONTARGET" : "Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial",
"ACCORD Lipid" : "Action to Control Cardiovascular Risk in Diabetes-Lipid",
"PEITHO" : "Pulmonary Embolism Thrombolysis trial",
"EPHESUS" : "Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study",
"LEADER" : "Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results",
"PROTECT AF" : "WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation",
"MAGELLAN" : "Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Acutely Ill Medical Patients Comparing Rivaroxaban with Enoxaparin",
"CAP-START" : "Community-Acquired Pneumonia—Study on the Initial Treatment with Antibiotics of Lower Respiratory Tract Infections",
"STAR-D" : "Sequenced Treatment Alternatives to Relieve Depression",
"EXCEL" : "XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL)",
"FREEDOM" : "Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease",
"STOP-IT" : "Study to Optimize Peritoneal Infection Therapy",
"AVERT" : "Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients",
"CASSINI" : "Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer",
"EVOLVE" : "Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis",
"EARLY-AF" : "Early Aggressive Invasive Intervention for Atrial Fibrillation",
"AUGUSTUS" : "An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention",
"FAME" : "Fractional Flow Reserve versus Angiography for Multivessel Evaluation",
"CHARM-Preserved" : "Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity-Preserved",
"ACURASYS" : "ARDS et Curarisation Systematique",
"FIDELIO-DKD" : "Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease",
"PREDIMED" : "Prevención con Dieta Mediterránea",
"ADJUST-PE" : "Age aDJUSTed D-Dimer to rule out PE",
"DETO2X-AMI" : "Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction",
"MATCH" : "Management of Atherothrombosis with Clopidogrel in High-risk patients",
"LOVIT" : "Lessening Organ Dysfunction with Vitamin C",
"PLATO" : "Platelet Inhibition and Patient Outcomes",
"EAST-AFNET 4" : "The Early Treatment of Atrial Fibrillation for Stroke Prevention Trial",
"ORIGIN n-3 Fatty Acids" : "Investigators in the outcome Reduction with an Initial Glargine Intervention",
"ART" : "Arterial Revascularization Trial",
"PATHWAY-2" : "Prevention and Treatment of Hypertension with Algorithm-Based Therapy (PATHWAY)",
"IRIS" : "International Randomized Study of Interferon and STI571",
"ASCEND" : "Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis",
"VANISH" : "Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs",
"ESPRIT" : "European/Australasian Stroke Prevention in Reversible Ischaemia Trial",
"ATHOS-3" : "Angiotensin II for the Treatment of High-Output Shock",
"PAUSE" : "Perioperative Anticoagulation Use for Surgery Evaluation",
"PROPPR" : "Pragmatic, Randomized Optimal Platelet and Plasma Ratios",
"DELIRIA-J" : "Delirium Intervention Research for Improving Acute phase outcomes in Japan",
"MOST" : "Ventricular pacing or dual-chamber pacing for sinus-node dysfunction",
"ADVOR" : "Acetazolamide in Decompensated Heart Failure With Volume OveRload",
"DINAMIT" : "Defibrillator in Acute Myocardial Infarction Trial",
"PROWESS" : "Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis",
"ARISTOTLE" : "Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation",
"ENGAGE AF-TIMI 48" : "Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation - Thrombolysis in Myocardial Infarction 48",
"CAMERA" : "Computer Assisted Management in Early Rheumatoid Arthritis",
"LIFE" : "Cardiovvascular Morbidity and Mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",
"COMPASS" : "Cardiovascular Outcomes for People Using Anticoagulation Stratgies",
"STAR" : "Study of Tamoxifen and Raloxifene (NSABP P-2)",
"SELECT" : "Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity",
"MPACT" : "Metastatic Pancreatic Adenocarcinoma Clinical Trial",
"DONATE HCV" : "Donors of Hepatitis C NAT Positive Thoracic Allografts for Transplantation Evaluation in Non-HCV Recipients",
"PARTNER A" : "Placement of Aortic Transcatheter Valves, Cohort A",
"SHIFT" : "Systolic Heart failure treatment with the If inhibitor ivabradine Trial",
"SONIC" : "Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease",
"PARAGON-HF" : "Prospective Comparison of ARNI Global Outcomes in HF with Preserved Ejection Fraction",
"MIRACL" : "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering",
"NCDS" : "The National Cooperative Dialysis Study",
"ACTIVE W" : "Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events",
"SEDCOM" : "Safety and Efficacy of Dexmedetomidine Compared with Midazolam",
"TRED-HF" : "Treatment for heart failure in patients with recovered dilated cardiomyopathy",
"PRAMI" : "Preventative Angioplasty in Acute Myocardial Infarction",
"GISSI-3" : "Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico",
"RACE II" : "Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II",
"AURORA" : "A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events",
"IABP-SHOCK II" : "Intraaortic Balloon Pump in Cardiogenic Shock II",
"VITAMINS" : "The VitamIn C, HydrocorTisone and ThiAMINe in Patients With Septic Shock Trial",
"PARTNER 2" : "Placement of Aortic Transcatheter Valves, Cohort A",
"VEST" : "Vest Prevention of Early Sudden Death",
"MRFIT" : "Multiple Risk Factor Intervention Trial",
"LoDoCo" : "Low-Dose Colchicine",
"CHAMPION PHOENIX" : "Cangrelor versus standard therapy to achieve optimal management of platelet inhibition",
"NA-ACCORD" : "North American AIDS Cohort Collaboration on Research and Design",
"RE-ALIGN" : "Randomized, Phase II Study to Evaluate the Safety and Pharmacokinetics of Oral Dabigatran Etexilate in Patients after Heart Valve Replacement",
"ASPREE" : "Aspirin in Reducing Events in the Elderly",
"BPROAD" : "Blood Pressure Control Target in Diabetes",
"CANVAS" : "Canagliflozin Cardiovascular Assessment Study",
"SEPSISPAM" : "Sepsis and Mean Arterial Pressure",
"AKIKI" : "Artificial Kidney Initiation in Kidney Injury",
"ALMS" : "Aspreva Lupus Management Study",
"ECST" : "European Carotid Surgery Trial",
"DEFINITE" : "Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation",
"WHI E+P" : "Women's Health Initiative Estrogen and Progestin Trial",
"RE-DUAL PCI" : "Randomized evaluation of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin in patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention",
"HPS2-THRIVE" : "Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events",
"COMET" : "Carvedilol Or Metoprolol European Trial",
"NSABP P-1" : "National Surgical Adjuvant Breast and Bowel Project, Prevention-1",
"VASST" : "Vasopressin and Septic Shock Trial",
"IALT" : "International Adjuvant Lung Cancer Trial",
"EMILIA" : "Emtansine vs. Capecitabine+Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer",
"WOEST" : "What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing",
"ATLAS ACS 2-TIMI 51" : "Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51",
"RELAX" : "Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction",
"ACCORD" : "Action to Control Cardiovascular Risk in Diabetes",
"VA NEPHRON-D" : "Veterans Affairs Nephropathy in Diabetes",
"Val-HeFT" : "Valsartan Heart Failure Trial",
"CRISTAL" : "Colloids Versus Crystalloids for the Resuscitation of the Critically Ill",
"HPS" : "Heart Protection Study Statin Arm",
"MIND-USA" : "Modifying the Impact of ICU-Associated Neurological Dysfunction–USA",
"CATT" : "Comparison of Age-Related Macular Degeneration Treatment Trails",
"TRACE-III" : "Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III",
"PRODIGE 4 ACCORD 11" : "PRODIGE 4 Actions concertées dans les Cancers COloRectaux et Digestifs",
"EDS" : "European Dexamethasone Study",
"SUP-ICU" : "Stress Ulcer Prophylaxis in the Intensive Care Unit",
"ROCKET AF" : "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation",
"ECASS III" : "European Cooperative Acute Stroke Study III",
"NLST" : "National Lung Screening Trial",
"SALT-ED" : "Saline Against Lactated Ringer's or Plasma-Lyte in the Emergency Department",
"COLCOT" : "Colchicine Cardiovascular Outcomes Trial",
"ISAR-TRIPLE" : "Triple therapy in Patients who Require Oral Anticoagulation After Drug-Eluting Stent Implantation",
"RAMPART" : "Rapid Anticonvulsant Medication Prior to Arrival Trial",
"ADRENAL" : "Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock",
"ACORN" : "Antibiotic Choice on Renal Outcomes",
"MASS" : "Multicentre Aneurysm Screening Study",
"POP-UP" : "Pantoprazole or Placebo for Stress Ulcer Prophylaxis",
"IMPROVE-IT" : "IMProved Reduction of Outcomes: Vytorin Efficacy International Trial",
"PESIT" : "Pulmonary Embolism in Syncope Italian Trial",
"BRIDGE" : "Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for Elective Invasive Procedure or Surgery",
"CURE" : "Clopidogrel in Unstable Angina to Prevent Recurrent Events",
"FOCUS" : "Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair",
"ORBITA" : "Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina",
"CASTLE-AF" : "Catheter Ablation versus Standard Conventional Therapy in Patients with Left Ventricular Dysfunction and Atrial Fibrillation",
"ATN" : "Acute Renal Failure Trial Network Study",
"TORCH" : "Towards a Revolution in COPD Health",
"ANNEXA-4" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of Factor Xa Inhibitors",
"TONE" : "Trial of Nonpharmacologic Interventions in the Elderly",
"STOPAH" : "Steroids or Pentoxifylline for Alcoholic Hepatitis",
"REMATCH" : "Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure",
"BICAR-ICU" : "Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill: A Multiple Center Randomized Clinical Trial",
"AAPAC" : "Appendicitis Acuta",
"MIDA" : "Mitral Regurgitation International Database",
"PALACE" : "The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge",
"VALIANT" : "Valsartan in Acute Myocardial Infarction Trial",
"UKPDS 34" : "UK Prospective Diabetes Study 34",
"BRIM-3" : "BRAF Inhibitor in Melanoma 3",
"PARTNER B" : "Placement of Aortic Transcatheter Valves, Cohort B",
"MSLT-I" : "Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma",
"CYTO-PV" : "Cytoreductive Therapy in Polycythemia Vera",
"AMPLIFY-EXT" : "Apixaban after the Initial Management of Pulmonary Embolism and Deep Vein Thrombosis with First-Line Therapy-Extended Treatment",
"FLAME COPD" : "Effect of Indacaterol Glycopyronium Vs. Fluticasone Salmeterol on COPD Exacerbations",
"STEP 1" : "Semaglutide Treatment Effect in People with Obesity 1",
"DAPA-CKD" : "Dapagliflozin in Chronic Kidney Disease",
"CONSENSUS" : "Cooperative North Scandinavian Enalapril Survival Study",
"ANTLER" : "Antidepressants to Prevent Relapse in Depression",
"PROPER" : "Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients",
"STICH" : "Surgical Treatment for Ischemic Heart Failure",
"HOPE-3" : "Heart Outcomes Prevention Evaluation-3",
"ROSE" : "Reevaluation of Systemic Early Neuromuscular Blockade",
"ACT" : "Acetylcysteine for Contrast-Induced Nephropathy Trial",
"ASTRAL" : "Angioplasty and Stenting for Renal Artery Lesions",
"MASTER DAPT" : "Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation with an Abbreviated versus Standard DAPT Regimen",
"MATRIX Antithrombin" : "Minimizing Adverse haemmhorragic events by TRansradial access site and systemic Implementation of angioX (MATRIX)",
"DIG" : "Digitalis Investigation Group",
"FLAME" : "Fluoxetine for Motor Recovery after Acute Ischaemic Stroke",
"RABBIT 2" : "Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes",
"METEOR" : "Meniscal Tear in Osteoarthritis Research",
"CORONA" : "Controlled Rosuvastatin Multinational Trial in Heart Failure",
"AF-CHF" : "Atrial Fibrillation and Congestive Heart Failure",
"NOTT" : "Nocturnal Oxygen Therapy Trial",
"WARFASA" : "Warfarin and Aspirin",
"IDEAL" : "Initiating Dialysis Early and Late",
"SADHAT" : "Sertraline Antidepressant Heart Attack Randomized Trial",
"DELIVER" : "Dapagliflozin Evaluation to Improve the Lives of Patients with Preserved Ejection Fraction Heart Failure",
"CATIE-AD" : "Clinical Antipsychotic Trials of Intervention Effectiveness–Alzheimer's Disease",
"MOPETT" : "Moderate Pulmonary Embolism Treated with Thrombolysis",
"NICE-SUGAR" : "Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation",
"ACTIVE A" : "Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events",
"NEAT-HFpEF" : "Nitrate’s Effect on Activity Tolerance in Heart Failure with Preserved Ejection Fraction",
"ELITE-Symphony" : "Efficacy Limiting Toxicity Elimination-Symphony",
"IST" : "International Stroke Trial",
"ATTRACT" : "Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis",
"FOURIER" : "Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk",
"ACCOMPLISH" : "Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension",
"DODS" : "D-dimer Optimal Duration Study",
"PROGRESS" : "Protection Against Recurrent Stroke Study",
"HPTN 052" : "HIV Prevention Trials Network 052 Study",
"SURTAVI" : "Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement",
"OAT" : "Occluded Artery Trial",
"POISE" : "PeriOperative ISchemic Evaluation",
"EMPHASIS-HF" : "Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure",
"VITAL" : "VITamin D and OmegA-3 TriaL",
"PRAETORIAN" : "Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy",
"NordICC" : "Nordic-European Initiative on Colorectal Cancer",
"UPLIFT" : "Understanding Potential Long-Term Impacts on Function with Tiotropium",
"CSG Captopril Trial" : "Collaborative Study Group Captopril Trial",
"ARTESIA" : "Apixaban for the Reduction of Thromboembolism in Patients with Device-Detected Subclinical Atrial Fibrillation",
"ODYSSEY LONG TERM" : "Long-term Safety and Tolerability of Alirocumab in High Cardiovascular Risk Patients with Hypercholesterolemia Not\nAdequately Controlled with Their Lipid Modifying Therapy",
"SHOCK" : "SHould we emergently revascularize Occluded Coronaries for Cardiogenic shocK",
"GISSI-HF" : "Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione"
}
}